References
- American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for growth hormone use in adults and children – 2003 update. Endocr Pract 2003;9:65–76
- Wit JM. Growth hormone therapy. Best Pract Res Clin Endocrinol Metab 2002;16:483–503
- Lindsay R, Feldkamp M, Harris D, et al. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994;125:29–35
- US Department of Commerce, Bureau of the Census, Current population estimates 2005. Accessed at http://www.census.gov, 20 August 2005
- Data on file, Novo Nordisk Inc., 2005
- National Institute for Clinical Excellence, guidance on the use of human growth hormone (somatropin) in children with growth failure. Technology Appraisal No. 42, May 2002
- Wessex Development and Education Committee (DEC). Growth hormone in children (for growth hormone deficiency, Turner’s syndrome, chronic renal failure and idiopathic short stature). Bristol: Wessex Institute for Health Research and Development; 1996. Report No. 57
- Rosser R, Cottee M, Rabin R, et al. Index of health-related quality of life. In: Hopkins A, editor. Measures of the quality of life. London: Royal College of Physicians; 1992
- Drug topics red book (update). Thomson Healthcare, March 2005
- Medicare physician fee schedule payment amount file. Baltimore (MD): Centers for Medicare and Medicaid Services, US Department of Health and Human Services, January 2005. Accessed at http://www.cms.hhs.gov/providers/pufdownload/default.asp#pfspayment, 20 August 2005
- Ogden CL, Fryar CD, Carroll MD, et al. Mean body weight, height, and body mass index, United States 1960–2002. Advance data from vital and health statistics; No. 347. Hyattsville (MD): National Center for Health Statistics; 2004
- Bryant J, Cave C, Mihaylova B, et al. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol Assess 2002;6:18–20